PCN29 Budgetary Impact of Adoption of Erlotinib for Lung Cancer in the Private Health Insurance Market in Brazil- A Real World Data Analysis
Nov 1, 2011, 00:00 AM
10.1016/j.jval.2011.08.1130
https://www.valueinhealthjournal.com/article/S1098-3015(11)02692-1/fulltext
Section Title :
Cancer
Section Order :
1085
First Page :
A438
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02692-1&doi=10.1016/j.jval.2011.08.1130